Beyond oncology, CD70-targeting AlloCAR70-NKT cells may have utility in T cell-mediated autoimmune diseases, where activated CD70+ T cells contribute to pathogenesis, including multiple sclerosis, inflammatory bowel disease, and lupus.91 Here, CD70 is linked to inflammatory bowel disease.